Skip to content
Baret News – Lifestyle
Author:
Applied Biologics
Applied Biologics Welcomes CMS FDA Coordination for Innovation
September 8, 2026
Applied Biologics Achieves Key Preclinical Milestone in Disease-Modifying Osteoarthritis Gene Therapy Program
September 3, 2026
Applied Biologics Activates First Clinical Site in Phase 3 BIOxHEAL™ Trial
September 1, 2026
Applied Biologics Announces Acceptance of Updated CAMPX XWRAP® Clinical Trial Results for Presentation at SAWC Fall 2026
August 25, 2026
Applied Biologics CEO and Former Marine F/A-18 Pilot Edward Britt Selected as Honorary Commander at Luke Air Force Base
August 24, 2026
Applied Biologics Welcomes CMS’ Continued Commitment to Clinical Evidence in Advanced Wound Care
August 19, 2026
Applied Biologics Announces Acceptance of XWRAP® Translational Research for Presentation at SAWC Fall 2026
August 18, 2026
Applied Biologics Launches National Health System Partnership Initiative
August 12, 2026
CMS Proposed 2027 Medicare Policy Continues Recognition of the FDA’s Section 351 Biologic Pathway
August 10, 2026
Applied Biologics Receives Central IRB Approval for Phase 3 BIOxHEAL™ Clinical Trial
August 5, 2026
1
2
3
Next Page
→